AstraZeneca is a science-led biopharmaceutical company pushing the boundaries of science to deliver life-changing medicines.

The company employs roughly 1,200 people in Canada who work to research, develop and market innovative medicines. AstraZeneca Canada was recently designated a global Clinical Hub for oncology and immuno-oncology clinical studies. We are currently leading global oncology clinical studies in lung, head, and neck cancer.

The future of treatment for many of today’s diseases lies in uncovering mechanisms that are newly emerging or are still to be discovered. We believe the best way to help patients is to focus on breakthrough science to discover these mechanisms and develop novel, targeted therapies that interact with them. Our focus is on the following core therapy areas: Cardiovascular, Renal and Metabolic diseases (CVRM); Oncology; Rare Disease; Respiratory & Immunology; and Vaccines & Immune Therapies.

In 2021, AstraZeneca invested more than $135.6 million in Canadian health sciences research in our core therapy areas.

AstraZeneca Canada was named Best Workplace Culture by the Canadian HR Awards in 2022 – a national award that recognizes best-in-class Canadian organizations with a commitment to strong and vibrant corporate cultures anchored to their people and values. The company was also recognized for Excellence for Financial, Physical & Mental Wellness by the Canadian HR awards. For the ninth consecutive year, AstraZeneca was named a Top Employer in the Greater Toronto Area, a reflection of our efforts to nurture a diverse and inclusive culture, support employee health and well-being, and create a dynamic and engaging work environment.